# A Study of ION537 in Patients With Molecularly Selected Advanced Solid Tumors

> **NCT04659096** · PHASE1 · COMPLETED · sponsor: **Ionis Pharmaceuticals, Inc.** · enrollment: 15 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** ION537

## Key facts

- **NCT ID:** NCT04659096
- **Lead sponsor:** Ionis Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-05
- **Primary completion:** 2022-10-19
- **Final completion:** 2022-10-19
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2022-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04659096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04659096, "A Study of ION537 in Patients With Molecularly Selected Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04659096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*